Position in GILD
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$462,150
-$55,076 QoQ
Shares Held
3,316
-21.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LGT Fund Management Co Ltd. holds $166,987,121 across 7 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
58,755 | $70,472,515 | |
| 2 | JNJ |
Johnson & Johnson
|
116,198 | $29,510,806 | |
| 3 | AZN |
Astrazeneca PLC
|
139,758 | $26,500,911 | |
| 4 | PFE |
Pfizer Inc
|
857,783 | $20,655,414 | |
| 5 | ABBV |
AbbVie Inc.
|
49,911 | $12,559,604 | |
| 6 | MRK |
Merck & Co., Inc.
|
39,522 | $5,078,577 | |
| 7 | AMGN |
Amgen Inc
|
6,101 | $2,209,294 |
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $462,150 | 3,316 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $517,226 | 4,214 | Shares | Defined | 2026-02-05 | |
| 2025-06-30 | $3,119,327 | 28,135 | Shares | Defined | 2025-07-22 | |
| 2025-03-31 | $2,765,954 | 24,685 | Shares | Defined | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||